Flex Pharma, Inc. Uncategorized Contracts & Agreements
27 Contracts & Agreements
- Form of Placement Agent Warrants (Filed With SEC on May 16, 2023)
- Form of Pre-Funded Warrants (Filed With SEC on May 16, 2023)
- Description of Registrant's Securities (Filed With SEC on March 18, 2021)
- At the Market Offering Agreement, dated February 5, 2021, by and among Salarius Pharmaceuticals, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 5, 2021)
- Form of Inducement Letter (Filed With SEC on December 11, 2020)
- Description of Registrants Securities (Filed With SEC on March 23, 2020)
- Royalty Agreement, dated January 2019, by and among Flex Innovation Group LLC, Bruce Bean, Donald MacKinnon, Roderick MacKinnon and Christoph Westphal (Filed With SEC on February 14, 2019)
- Restricted Unit Award Agreement, dated January 21, 2017, between Sunil Sharma and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Restricted Unit Award Agreement, dated January 21, 2017, between Jonathan P. Northrup and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Restricted Unit Award Agreement, dated January 21, 2017, between Scott Jordan and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Restricted Unit Award Agreement, dated August 1, 2016, between David J. Arthur and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Manager Agreement, dated January 21, 2017, between Sunil Sharma and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Manager Agreement, dated January 21, 2017, between Jonathan P. Northrup and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Cancer Research Grant Contract, dated June 1, 2016, between the Cancer Prevention and Research Institute of Texas and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Exclusive Pharmaceutical Sublicense Agreement, dated November 25, 2016, between HLB LifeScience Co., Ltd. and Salarius Pharmaceuticals, LLC (Filed With SEC on February 14, 2019)
- Lock-up Agreement for the benefit of Salarius Pharmaceuticals, LLC executed by David J. Arthur (Filed With SEC on January 4, 2019)
- Lock-up Agreement for the benefit of Salarius Pharmaceuticals, LLC executed by William K. McVicar (Filed With SEC on January 4, 2019)
- Advisor Agreement, dated June 26, 2018, by and between the Registrant and Thomas Wessel (Filed With SEC on August 1, 2018)
- Amendment to Offer Letter, effective as of January 8, 2018, by and between the Company and Thomas Wessel (Filed With SEC on January 12, 2018)
- FLEX INNOVATION GROUP LLC ADVISOR AGREEMENT Date: August 24, 2016 (Filed With SEC on November 2, 2016)
- PRODUCTION AGREEMENT (Filed With SEC on May 4, 2016)
- Prudential Tower 800 Boylston Street Floor 24 Boston, MA 02199 www.flex-pharma.com (Filed With SEC on March 8, 2016)
- FLEX PHARMA, INC. INDEMNITY AGREEMENT (Filed With SEC on January 13, 2015)
- FOUNDERS AGREEMENT (Filed With SEC on December 29, 2014)
- ROYALTY AGREEMENT (Filed With SEC on December 29, 2014)
- Prudential Tower 800 Boylston Street Floor 24 Boston, MA 02199 VOX 617-874-182 www.flex-pharma.com (Filed With SEC on December 29, 2014)
- Exhibit A (Filed With SEC on December 29, 2014)
